New developments in the conduct of clinical trials
Covid19 changed many of the established procedures. Study designs also had to be adapted to the new reality of conducting clinical trials. This was accompanied by an increase in the integration and use of digital structures in clinical trials. Patients could no longer visit the trial centre, so telephone and video visits were introduced. Monitors could not visit the trial sites, so new ways had to be found to ensure data quality.
Some of these innovations have proven to be helpful and beneficial to trials, for example by facilitating patient recruitment, increasing patient retention and saving time and money. These are benefits that are hard to resist, and the trend is moving away from traditional trials and towards decentralised or hybrid trials.
However, with new concepts come new questions and obstacles that need to be considered and solved. LKF, ABF and AMEDON, have worked together in a workshop to develop solutions that we adapt to our customers' needs.
AMEDON, which specialises in the development and provision of web-based solutions for clinical trials, has prepared simple and secure solutions that can be quickly adapted to the client's needs.
ABF, with its dense global GMP depot network and EU GMP labelling and packaging facility, can, consideration of national regulatory guidelines in each country, ensure the safe distribution of trial supplies, even for decentralised studies.
LKF, the central laboratory for Phase I - IV clinical trials in northern Germany, reliably organises the transport of test kits to the sites, the collection of samples to the analysis centre in Kiel and, of course, the analyses.
We know every project is unique and every project has specific requirements. Together with the customer we find the best solution. Our tailored solutions and central laboratory services help you to optimize processes and ensure the validity and integrity of all laboratory data and processes.